Interaction between Brk kinase and insulin receptor substrate-4

Oncogene

Volumn 24, Issue 36, 2005, Pages 5656-5664

  Qiu, Haoqun ^a   Zappacosta, Francesca ^b   Su, Wenjuan ^a   Annan, Roland S ^b   Miller, W Todd ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

Brk; IRS 4; Tyrosine kinase

Indexed keywords

BREAST TUMOR KINASE; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 4; PROTEIN TYROSINE KINASE; SOMATOMEDIN C; UNCLASSIFIED DRUG; INSULIN RECEPTOR SUBSTRATE 1 PROTEIN; INSULIN RECEPTOR SUBSTRATE-1 PROTEIN; IRS4 PROTEIN, HUMAN; PHOSPHOPROTEIN; PTK6 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR PROTEIN;

ARTICLE; CARCINOMA CELL; CELL STIMULATION; CELL STRAIN HEK293; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SQUAMOUS CELL CARCINOMA; CELL LINE; DRUG EFFECT; ENZYME ACTIVATION; METABOLISM; PHOSPHORYLATION; PROTEIN BINDING; SIGNAL TRANSDUCTION;

MINK CELL FOCUS-FORMING VIRUS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL LINE; ENZYME ACTIVATION; HUMANS; INSULIN-LIKE GROWTH FACTOR I; NEOPLASM PROTEINS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION;

EID: 24644462342     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1208721     Document Type: Article

References (34)

1. Barker KT, Jackson LE and Crompton MR. (1997). Oncogene, 15, 799-805.
2. Chen H-Y, Shen C-H, Tsai Y-T, Lin F-C, Huang Y-P and Chen R-H. (2004). Mol. Cell. Biol., 24, 10558-10572.
3. Derry JJ, Prins GS, Ray V and Tyner AL. (2003). Oncogene, 22, 4212-4220.
4. Derry JJ, Richard S, Valderrama Carvajal H, Ye X, Vasioukhin V, Cochrane AW, Chen T and Tyner AL. (2000). Mol. Cell. Biol., 20, 6114-6126.
5. Escribano O, Fernandez-Moreno MD, Zueco JA, Menor C, Fueyo J, Ropero RM, Diaz-Laviada I, Roman ID and Guijarro LG. (2003). Hepatology, 37, 1461-1469.
6. Fantin VR, Keller SR, Lienhard GE and Wang LM. (1999). Biochem. Biophys. Res. Commun., 260, 718-723.
7. Fantin VR, Sparling JD, Slot JW, Keller SR, Lienhard GE and Lavan BE. (1998). J. Biol. Chem., 273, 10726-10732.
8. Fantin VR, Wang Q, Lienhard GE and Keller SR. (2000). Am. J. Physiol. Endocrinol. Metab., 278, E127-E133.
9. Giovannone B, Scaldaferri ML, Federici M, Porzio O, Lauro D, Fusco A, Sbraccia P, Borboni P, Lauro R and Sesti G. (2000). Diabetes Metab. Res. Rev., 16, 434-41.
10. Harvey AJ and Crompton MR. (2003). Oncogene, 22, 5006-5010.
11. Harvey AJ and Crompton MR. (2004). Anticancer Drugs, 15, 107-111.
12. Joyal JL, Annan RS, Ho YD, Huddleston ME, Carr SA, Hart MJ and Sacks DB. (1997). J. Biol. Chem., 272, 15419-15425.
13. Kamalati T, Jolin HE, Fry MJ and Crompton MR. (2000). Oncogene, 19, 5471-5476.
14. Kamalati T, Jolin HE, Mitchell PJ, Barker KT, Jackson LE, Dean CJ, Page MJ, Gusterson BA and Crompton MR. (1996). J. Biol. Chem., 271, 30956-30963.
15. Karas M, Koval AP, Zick Y and LeRoith D. (2001). Endocrinology, 142, 1835-1840.
16. Koval AP, Karas M, Zick Y and LeRoith D. (1998). J. Biol. Chem., 273, 14780-14787.
17. Lavan BE, Fantin VR, Chang ET, Lane WS, Keller SR and Lienhard GE. (1997). J. Biol. Chem., 272, 21403-21407.
18. Lingohr MK, Dickson LM, Wrede CE, Briaud I, McCuaig JF, Myers Jr MG and Rhodes CJ. (2003). Mol. Cell Endocrinol., 209, 17-31.
19. Llor X, Serfas MS, Bie W, Vasioukhin V, Polonskaia M, Derry J, Abbott CM and Tyner AL. (1999). Clin. Cancer Res., 5, 1767-1777.
20. McCormack AL, Schieltz DM, Goode B, Yang S, Barnes G, Drubin D and Yates III JR. (1997). Anal. Chem., 69, 767-776.
21. Mitchell PJ, Barker KT, Martindale JE, Kamalati T, Lowe PN, Page MJ, Gusterson BA and Crompton MR. (1994). Oncogene, 9, 2383-2390.
22. Mitchell PJ, Sara EA and Crompton MR. (2000). Oncogene, 19, 4273-4282.
23. Perkins DN, Pappin DJ, Creasy DM and Cottrell JS. (1999). Electrophoresis, 20, 3551-3567.
24. Qiu H and Miller WT. (2002). J. Biol. Chem., 277, 34634-34641.
25. Qiu H and Miller WT. (2004). Oncogene, 23, 2216-2223.
26. Qu BH, Karas M, Koval A and LeRoith D. (1999). J. Biol. Chem., 274, 31179-31184.
27. Sesti G. (2000). Pharmacogenomics, 1, 343-357.
28. Sesti G, Federici M, Hribal ML, Lauro D, Sbraccia P and Lauro R. (2001). FASEB J., 15, 2099-2111.
29. Sun XJ, Pons S, Wang LM, Zhang Y, Yenush L, Burks D, Myers Jr MG, Glasheen E, Copeland NG, Jenkins NA, Pierce JH and White MF. (1997). Mol. Endocrinol., 11, 251-262.
30. Tseng YH, Kriauciunas KM, Kokkotou E and Kahn CR. (2004). Mol. Cell. Biol., 24, 1918-1929.
31. Uchida T, Myers Jr MG and White MF. (2000). Mol. Cell Biol., 20, 126-138.
32. Vasioukhin V, Serfas MS, Siyanova EY, Polonskaia M, Costigan VJ, Liu B, Thomason A and Tyner AL. (1995). Oncogene, 10, 349-357.
33. Vasioukhin V and Tyner AL. (1997). Proc. Natl. Acad. Sci. USA, 94, 14477-14482.
34. Zhang P, Ostrander JH, Faivre EJ, Olsen A, Fitzsimmons D and Lange CA. (2005). J. Biol. Chem., 280, 1982-1991.